education & resources
News & Events
previous
next

careviso and Xifin Collaborate on MRD Article

careviso and Xifin recently teamed up to publish an article exploring MRD (Minimal Residual Disease) testing. Co-authored by Shauna Hay, careviso’s VP of Clinical Operations, and Heather Agostinelli, Xifin’s Vice President & Head of Specialty RCM, the article provides an in-depth look at what MRD testing entails, its purpose, and strategies for achieving success in this critical area.


Read the article

About careviso

As one of the industry’s leading healthcare technology companies, careviso created a complete technology platform, seeQer, that increases patient access to care by delivering cost estimates, administrative requirements, and approvals in real time through streamlined workflows.

careviso began with a laboratory-focused approach and has expanded to serve a wider population in healthcare. Our mission is to support patients, providers, and payors with total access to healthcare. By automating the impossible, we’re solving the most complex problems in the healthcare industry: prior authorizations and financial transparency.

Download as PDF
December 16, 2024
Share this post

I am the text that will be copied.

Back to All news
Back to top
Book your software demo

Discover how seeQer informs patients and transforms practice.

Schedule a seeQer demonstration of benefits verifications, cost assessments, and other essential tasks in the platform. Learn how seeQer can help your organization reduce administrative burden, transform cumbersome processes, and provide transparency that empowers patients in a complex and ever-changing industry.

Submit Enrollment
Book a Demo